ClinicalTrials.gg
Active, not recruitingNCT05708092Updated Feb 23, 2026

NRF for Improved Re-Entry Outcomes for Offenders With Brain Injury (Brain Injury RE)

An interventional study of NeuroResource Facilitation (NRF) in Brain Injury, sponsored by Icahn School of Medicine at Mount Sinai. Active, not recruiting at 2 sites in United States. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-23.

Sponsored by Icahn School of Medicine at Mount Sinai · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Mar 2022, registered Jan 2023).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,022
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 312 studies in Brain Injuries with a site in United States — 57 open to participants now, 69 under way, none of them phase 3. Brain Injuries · United States.

Enrollment
4th of 223
1,022 · median 42
Started
2022
with 10 others
No phase
152 of 312
30 open now
Primary completion
2026-12
later than 19 of 68 live
Registered
240th of 312
by date
Lead sponsor
9 of 312
Icahn School of Medicine at Mount Sinai

Among the 312 studies in Brain Injuries with a site in United States, this one is the 4th largest by enrollment of the 223 interventional ones that give a count, is one of 11 that started in 2022, is one of 152 with no phase, reaches primary completion later than 19 of the 68 other live ones, and was the 240th registered.

Brain Injuries

947 studies on the registry are indexed under Brain Injuries; 234 are open to participants now.

Browse Brain Injuries studies →

Open to participants now

57 of the 312 studies in Brain Injuries with a site in United States are open now. Recruiting first, the newest first:

52 more — sign in →

All 57 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 152 Brain Injuries studies recruiting now, 77 (51%) set no upper age limit and 53 (35%) stop at 75 or younger; 38 take children under 18; 23 take healthy volunteers.

This study: 18 Years and older · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 312 studies in Brain Injuries with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to evaluate the effectiveness of NeuroResource Facilitation, a novel/innovative intervention, in reducing recidivism in offenders with brain injury (BI).

Read the detailed description

The prevalence of brain injury (BI) is significantly greater in justice-involved populations, and a substantial proportion of prisoners have likely experienced a BI during their lifetime. A history of BI has a statistically significant association with increased use of correctional, medical and psychological services including crisis intervention; an increased frequency of institutional misconducts; and higher recidivism rates. Brain injury in justice-involved populations is frequently undiagnosed, and therefore untreated, which contributes to the cycle of recidivism. Identifying BI opens up new resources to ex- offenders that can more effectively help them to become productive in their lives in the community. In partnership with the Icahn School of Medicine at Mount Sinai, the Brain Injury Association of Pennsylvania, and the Pennsylvania Department of Corrections (PADOC), this project will implement a randomized clinical trial to determine if a case management intervention called Neurorehabilitation Facilitation (NRF) is effective in reducing recidivism by ten percent in offenders with acquired BI. Offenders in two Pennsylvania prisons (State Correctional Institution (SCI) sites in PA, SCI Phoenix, SCI Chester, SCI Frackville, and SCI Mahanoy) will be screened for BI and cognitive impairment, and those who screen positive will be randomized to receive the intervention or to receive standard of care (SoC). Two thirds of those randomized will receive the intervention and the remaining one third will serve as controls. All participants will be followed for up to three years following their release to examine the immediate and long-term reduction in recidivism.

The primary hypothesis is that NRF, as compared to SoC, will result in a 10% reduction in average 1-year recidivism, estimated by the 2013

Department of Corrections (DOC) report as 35-38%. Understanding that additional factors will contribute to the effect of NRF, the required sample was based on the primary analysis, a logistic regression of the binary response variable recidivism, adjusted for additional independent variables (described below) in the model with estimated R-squared=0.10. An effect size of 10% reduction corresponds to an odds ratio in this model of 0.643. With two thirds (67%) of cases randomized to NRF, and one third (33%) randomized to SoC, a total sample of N=688 provides 80% power at alpha set at 0.05. Anticipating that there will be a loss of approximately 10% of randomized cases to attrition, N=764 cases will be randomized, with n=509 cases randomized to NRF and 255 randomized to SoC.

03

Conditions studied

  • Brain Injury

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18+ years old
  • Proficient in English
  • History of brain injury (OSU-TBI-ID)
  • Significant cognitive impairment (RBANS and Trails A\&B)
  • Within 6 months of release
  • Returning to 6 county area (Bucks, Chester, Delaware, Montgomery, Philadelphia and Schuylkill)

Exclusion criteria

Exclusion Criteria:

  • Non-English Speaking
  • Under 18 years old
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
1,022 participants (actual)

Study arms

  • Active comparator
    NeuroResource Facilitation

    As part of the NRF intervention group, participants will receive specialized care management, both in prison and after the participant goes home. While in the State Correctional Institution (SCI), participants will meet weekly to monthly depending on resource needs, and how close participant is to release with a NeuroResource Facilitator in person who will help participants to understand more about their challenges. Participants may also be referred to a group run by the Facilitator in conjunction with staff from the prison. The facilitator will also tell the participant about resources that are available to help after the participant's release and help participants get connected to them.

    Behavioral: NeuroResource Facilitation (NRF)

  • No intervention
    Standard of Care

    As part of the SoC, participants will receive the re-entry services normally receive if not in the study including (but not limited to) Treatment Services, Educational and Vocational Training, Mental Health Management, Reentry and Transitional Services, Population Management and Community Corrections.

Interventions

  • BehavioralNeuroResource Facilitation (NRF)

    NRF is defined as a specialized service that promotes access to services and coordinates care specific to the needs of individuals with brain injury. Possible resources include vocational services, medical assistance, Social Security (SSI or SSDI if appropriate), and other organizations that can support reentry. If needed to gain access to services and organizations, the facilitator will also provide participants with a summary that includes results from brain injury screenings questionnaire, neurocognitive (thinking abilities) tests, and symptoms. The researchers will share information and coordinate with prison and parole staff about participation in the study. Participant's information will also be shared with resources that could help participants after release, such as funding sources and brain injury services. After release from SCI, the NRF facilitator will assist the participant with all the preparation and logistics associated with the resources the participant applied to.

06

What researchers measure

Primary outcomes

  1. Number of Recidivism

    According to the PADOC, rearrest is measured as the first instance of arrest after inmates are released from state prison and reincarceration is measured as the first instance of returning to state prison after an offender is released from state prison. Overall recidivism is measured as the first instance of any type of rearrest or reincarceration after inmates are released from state prison.

    Time frame: at year 1

  2. Number of Recidivism

    According to the PADOC, rearrest is measured as the first instance of arrest after inmates are released from state prison and reincarceration is measured as the first instance of returning to state prison after an offender is released from state prison. Overall recidivism is measured as the first instance of any type of rearrest or reincarceration after inmates are released from state prison.

    Time frame: at year 3

Secondary outcomes

  1. Number of Productive Activities Hours

    Productive Activities Hours include competitive employment (hours worked), and volunteer work (hours worked), brain injury clubhouses (hours attended), vocational training program (hours attended), and education (hours attended).

    Time frame: up to 36 months post release

  2. Number or Participants Engaged in Productive Activity

    The number of participants who engage in vocational training program or education activity at end of program.

    Time frame: up to 36 months post release

  3. Number of Participants Engaged with Services

    Engagement with Services. Engagement with Services includes community-based specialized NeuroRehabilitation services (physical therapy, occupational therapy, speech therapy, cognitive rehabilitation therapy, neuropsychology), and vocational rehabilitation services (job development, job placement, job coaching).

    Time frame: up to 36 months post release

  4. Number of Participants Connected to Health/Medical Resources

    The connection to Health/Medical resources will also be measured, "safety net" resources (SNAP, MA, SSI, food bank, etc).

    Time frame: up to 36 months post release

  5. Number of participants in Community Support

    Community Support - Participation in support groups and recovery resources, including religious activities, recreation, and access to transportation.

    Time frame: up to 36 months post release

  6. Number of Participants in Stable Housing

    Community Support - whether the ex-offender has stable housing

    Time frame: up to 36 months post release

  7. Number of Parole Obligations Met

    Parole Obligations - the extent to which the ex- offender has satisfied the obligations of Parole will be tracked, such as whether they have completed all mandated treatment

    Time frame: up to 36 months post release

  8. Number of Participants Discharged from Supervision

    Number of participants that have been or (are likely to be) discharged from supervision.

    Time frame: up to 36 months post release

  9. Date of Reception

    The day on which an individual was initially received into the custody

    Time frame: up to 36 months post release

  10. Date Committed

    The day on which an individual was committed to sentenced

    Time frame: up to 36 months post release

  11. Date of entry into Department of Corrections

    The day on which an individual was admitted into the Department of Corrections

    Time frame: up to 36 months post release

  12. Number of Participants with particular Classification of Offense

    Number of Participants with particular Classification of Offense as listed by the Department of Corrections

    Time frame: up to 36 months post release

  13. Number of participants who are Guilty but mentally ill

    Number of participants who are guilty but mentally ill

    Time frame: up to 36 months post release

  14. Number of Participants Recommended for aftercare

    Number of Participants Recommended to receive aftercare

    Time frame: up to 36 months post release

  15. Status of Participants after Program completion

    Status of Participants after Program completions as determined by the Department of Corrections

    Time frame: up to 36 months post release

  16. Program category

    Program category as as determined by the Department of Corrections

    Time frame: up to 36 months post release

07

Study locations

2 sites
  • Icahn School of Medicine at Mount Sinai
    New York, New York 10065, United States
  • Brain Injury Association of Pennsylvania
    Carlisle, Pennsylvania 17015, United States
08

References and documents

Individual participant data

Plan to share: Yes — All of the individual participant data collected during the trial, after deidentification.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Immediately following publication. No end date.

Access criteria: Researchers who provide a methodologically sound proposal. To achieve aims in the approved proposal. Proposals should be directed to maria.kajankova@mountsinai.org. To gain access, data requestors will need to sign a data access agreement. Data are available for 5 years at a third party website (Link tbd).

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2022 (actual). Primary completion is estimated for Dec 2026, 57 months after the start.

Of 285 non-industry interventional studies with no phase under Brain Injuries, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 57 months is above that.

Counting every sponsor, half of 298 studies reached it within 24 months; a quarter within 12 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 23, 2023
First posted
Feb 1, 2023
StartActual
Mar 22, 2022
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Feb 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05708092
Collaborators
Brain Injury Association of Pennsylvania
Responsible party
Maria Kajankova (Associate Professor, Icahn School of Medicine at Mount Sinai) — Principal investigator
First posted
Feb 1, 2023
Start date
Mar 22, 2022
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Feb 23, 2026

Study contacts

Maria Kajankova, PhD
principal investigator · Icahn School of Medicine at Mount Sinai

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion